.png)
Leading experts emphasize encouraging policies, upgradation of educational courses and increasing awareness among farmers for better adoption of latest technologies
Exiting of targeted product line expected to further strengthen the performance chemicals segment and improve Ingevity’s overall earnings and cash flow profile
Mitsubishi Chemical operates a phenol plant with a 280,000-ton capacity at its Ibaraki Plant
The updated agreement specifies volume and pricing details for the first two products
With both plants, Sika will be able to respond better to local market demands
Possible collaborations could potentially commence commercial lithium production by 2027
The acquisition of the Nexchlor HCl business builds upon Jones-Hamilton’s strategic focus on strengthening its position as one of North America’s premier sources of hydrochloric acid
The company plans a new capex for production of speciality products at an investment of Rs. 120 crore, funded through internal accruals
Glasurit and R-M among BMW Group’s preferred paint brands for its aftersales network in selected markets
The new flame-retardant grade enhances safety with excellent thermal shock resistance and electrical isolation
With tough environmental norms and data protection concerns in China, Indian CDMOs could emerge as a potential replacement
BASF will increase prices for its Lupranate TDI by $300 per metric ton in ASEAN and South Asia.
MoU reinforces commitment on sustainable tire manufacturing through innovative circular silica
India's annual demand for toluene stands at about 650 TMT but domestic production currently is about 160 TMT
he Avoca business line represents the last entity from Ashland’s previous acquisition of Pharmachem
The proposed plan focuses on streamlining operations
These luminaries, whose contributions have left a lasting impact on the nation’s development, will be bestowed with the prestigious title Rasayan Udyog Maharshi
This is the first time a Made in India product under HALS has been exported to various parts of the globe with the Make In India label
Increases speed to market for drug developers working on nucleic acid therapeutics
The completion of the sale is expected by mid-2025
Subscribe To Our Newsletter & Stay Updated
